Cargando…
The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis
BACKGROUND: Rare diseases (RDs) affect less than 5/10,000 people in Europe and fewer than 200,000 individuals in the United States. In rheumatology, RDs are heterogeneous and lack systemic classification. Clinical courses involve a variety of diverse symptoms, and patients may be misdiagnosed and no...
Autores principales: | Leyens, Judith, Bender, Tim Th. A., Mücke, Martin, Stieber, Christiane, Kravchenko, Dmitrij, Dernbach, Christian, Seidel, Matthias F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296612/ https://www.ncbi.nlm.nih.gov/pubmed/34294115 http://dx.doi.org/10.1186/s13023-021-01945-8 |
Ejemplares similares
-
Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis
por: Bender, Tim T. A., et al.
Publicado: (2020) -
Ankylosing spondylitis
Publicado: (1980) -
Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010) -
Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976) -
Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)